| __timestamp | Ligand Pharmaceuticals Incorporated | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 64538000 | 118223000 |
| Thursday, January 1, 2015 | 71914000 | 187296000 |
| Friday, January 1, 2016 | 108973000 | 245015000 |
| Sunday, January 1, 2017 | 141102000 | 321139000 |
| Monday, January 1, 2018 | 251453000 | 359111000 |
| Tuesday, January 1, 2019 | 120282000 | 299255000 |
| Wednesday, January 1, 2020 | 186419000 | 248234000 |
| Friday, January 1, 2021 | 277133000 | 258615000 |
| Saturday, January 1, 2022 | 196245000 | 267841000 |
| Sunday, January 1, 2023 | 131314000 | 321477000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, Ligand Pharmaceuticals and MiMedx Group have showcased intriguing revenue trajectories over the past decade. From 2014 to 2023, Ligand Pharmaceuticals experienced a revenue growth of approximately 103%, peaking in 2021 with a remarkable 278 million USD. However, the subsequent years saw a decline, closing at 131 million USD in 2023. In contrast, MiMedx Group demonstrated a more consistent upward trend, with revenues increasing by 172% over the same period, reaching a high of 321 million USD in 2023.
These trends reflect the dynamic nature of the biotech industry, where innovation and market forces drive financial outcomes.
Revenue Showdown: Vertex Pharmaceuticals Incorporated vs MiMedx Group, Inc.
Annual Revenue Comparison: GSK plc vs MiMedx Group, Inc.
United Therapeutics Corporation and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
Walgreens Boots Alliance, Inc. and MiMedx Group, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Who Generates More Revenue? Cytokinetics, Incorporated or Ligand Pharmaceuticals Incorporated
Cytokinetics, Incorporated vs MiMedx Group, Inc.: Examining Key Revenue Metrics
Revenue Insights: Alkermes plc and Ligand Pharmaceuticals Incorporated Performance Compared
Perrigo Company plc vs MiMedx Group, Inc.: Examining Key Revenue Metrics
Annual Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Evotec SE
Cost Insights: Breaking Down Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc.'s Expenses
Annual Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs MiMedx Group, Inc.